Teva Pharmaceutical Industries Ltd | TEVA - Selling And Administration Expenses

Teva Pharmaceutical reported $837M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Selling And Administration Expenses Change
Aspen Pharmacare APN:SJ ZAR 4.25B 35M
Cipla CIPLA:IN INR 9.49B 121.2M
Dr.Reddys Laboratories DRRD:IN INR 28.36B 2.53B
Guangzhou Baiy 600332:CH CNY 2.05B 230.15M
Jiangsu Hengrui Me. 600276:CH CNY 2.37B 415.39M
Kalbe Farma Tbk Pt KLBF:IJ IDR 1.54T 64.52B
Richter Gedeon RICHT:HB HUF 44.88B 1.41B
Sh Fosun Pharma 600196:CH CNY 3.93B 656.16M
Sun Pharmaceuticals SUNP:IN INR 20.37B 325.1M
Teva Pharmaceutical TEVA:IT USD 837M 60M